Serving Size:1 Capsule … Amount PerServing …
Methylsulfonylmethane (MSM) … 1000 mg
Non-medicinal ingredients: Capsule: hypromellose
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish, shellfish or any animal byproduct.
What Is It?
MSM or methylsulfonylmethane is a naturally occurring form of organic sulfur found in living organisms. In humans, sulfur is present throughout the body in several organic compounds and is a factor in a number of different processes in the body. Sulfur is used to produce vital nutrients such as amino acids, including taurine (which stabilizes cell membranes), and methionine (which detoxifies cells and is involved in pain relief). MSM holds our basic connective tissues together, forming the elemental structure of proteins, and is required for a number of catalytic functions of various enzymes, meaning that without sulfur these enzymes cannot even start their essential activity.
What Does It Do?Primary Uses: MSM is primarily used to reduce the symptoms of knee pain and reduced physical function in osteoarthritis due to its anti-inflammatory and connective tissue supporting activities. It may also help reduce muscle pain and cramps due to its ability to reduce lactic acid production.Secondary Uses: MSM is useful for ameliorating the symptoms of seasonal allergic rhinitis and other types of allergies.
Who Should Take It?
MSM is valuable to those who suffer from any type of inflammation or inflammatory joint disorders, for those with allergies or those simply looking for a good dietary source of sulfur.
Take 1 capsule three times a day with food, or as directed by a qualified health care practitioner. Use for a minimum of 4 weeks to see beneficial effects.
Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. (2002) “A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis.” J Altern Complement Med Apr; 8(2): 167-73.
Jacob SW, Herschler R. (1983) “Dimethylsulfoxide; after twenty years”. Ann N Y Acad Sci; 411:xiii-xvii.
Lawrence RM. (1998) “Methylsulfonylmethane (MSM): A double-blind study of its use in degenerative arthritis”. Int J Anti-Aging Med. Summer; I(I); 50.
Moore RD, Morton JI. “Dimminished inflammatory joint disease in MRL/1pr mice ingesting Dimethlysulfoxide (DMSO) or Methylsulfonylmethane (MSM).” Fed Proc 1985 Mar; 44(3): 530 (Abs 692).
Morton JI, Larrain B, Nairn CS, and Siegel BV. “IgG3 Cryoglobulinemia in MRL/1pr mice and its modification by DMSO and DMSO2 therapy.” FASEB J 1992 Fe26; 6(4): A1450 (Abs 2979)
Murav'ev IuV, Venikova MS, Pleskovskaia GN, Riazantseva TA, Sigidin IaA. (1991) “Effect of dimethyl sulfoxide and dimethylsulfone on a destructive process in the joints of mice with spontaneous arthritis”. Patol Fiziol Eksp Ter Mar-Apr;(2):37-9
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.